RDEA3170 and Allopurinol Combination Study in Gout Subjects

NCT02279641 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout

Interventions

DRUG: RDEA3170 10 mg
DRUG: allopurinol 300 mg

Sponsor

Ardea Biosciences, Inc.